BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 27094586)

  • 1. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.
    Bartsch E; Medcalf KE; Park AL; Ray JG;
    BMJ; 2016 Apr; 353():i1753. PubMed ID: 27094586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
    Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
    Poon LC; Wright D; Rolnik DL; Syngelaki A; Delgado JL; Tsokaki T; Leipold G; Akolekar R; Shearing S; De Stefani L; Jani JC; Plasencia W; Evangelinakis N; Gonzalez-Vanegas O; Persico N; Nicolaides KH
    Am J Obstet Gynecol; 2017 Nov; 217(5):585.e1-585.e5. PubMed ID: 28784417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials.
    Villa PM; Kajantie E; Räikkönen K; Pesonen AK; Hämäläinen E; Vainio M; Taipale P; Laivuori H;
    BJOG; 2013 Jan; 120(1):64-74. PubMed ID: 23126307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
    Al-Rubaie Z; Askie LM; Ray JG; Hudson HM; Lord SJ
    BJOG; 2016 Aug; 123(9):1441-52. PubMed ID: 27225348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis.
    Al-Rubaie ZTA; Askie LM; Hudson HM; Ray JG; Jenkins G; Lord SJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():159-166. PubMed ID: 30199814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial.
    Odibo AO; Goetzinger KR; Odibo L; Tuuli MG
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):414-8. PubMed ID: 25914193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents for preventing and treating pre-eclampsia.
    Knight M; Duley L; Henderson-Smart DJ; King JF
    Cochrane Database Syst Rev; 2000; (2):CD000492. PubMed ID: 10796208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
    Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Khalil A; Thilaganathan B
    BJOG; 2021 Jan; 128(2):149-156. PubMed ID: 32613730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of body mass index in predicting pre-eclampsia: bivariate meta-analysis.
    Cnossen JS; Leeflang MM; de Haan EE; Mol BW; van der Post JA; Khan KS; ter Riet G
    BJOG; 2007 Dec; 114(12):1477-85. PubMed ID: 17903233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis.
    Rossi AC; Mullin PM
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):9-16. PubMed ID: 21641104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
    Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
    Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
    Roberge S; Nicolaides K; Demers S; Hyett J; Chaillet N; Bujold E
    Am J Obstet Gynecol; 2017 Feb; 216(2):110-120.e6. PubMed ID: 27640943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening.
    Park F; Russo K; Williams P; Pelosi M; Puddephatt R; Walter M; Leung C; Saaid R; Rawashdeh H; Ogle R; Hyett J
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):419-23. PubMed ID: 25678383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation.
    Block-Abraham DM; Turan OM; Doyle LE; Kopelman JN; Atlas RO; Jenkins CB; Blitzer MG; Baschat AA
    Obstet Gynecol; 2014 Mar; 123(3):611-617. PubMed ID: 24513777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological prevention of pre-eclampsia.
    Dekker GA
    Baillieres Clin Obstet Gynaecol; 1995 Sep; 9(3):509-28. PubMed ID: 8846553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis.
    Ghesquiere L; Guerby P; Marchant I; Kumar N; Zare M; Foisy MA; Roberge S; Bujold E
    Am J Obstet Gynecol MFM; 2023 Jul; 5(7):101000. PubMed ID: 37146687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is testing for aspirin response worthwhile in high-risk pregnancy?
    Rey E; Rivard GE
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):38-42. PubMed ID: 21440360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.